NEXT

New Jersey Law Journal

J&J Subsidiary Files Suit Against Former Employee for Breach of Noncompete, Accuses Competitor of Poaching Marketing Staff

"Through its most recent hirings, STAAR aims to essentially hire the entire J&J Vision marketing team at a critical time for J&J Vision's business and in the midst of its execution of its short-term and long-term strategic plans," the complaint said.
3 minute read

The Legal Intelligencer

SEC Agrees to Dismiss Civil Suit Against Former Pharma CIO Over Alleged Insider Trading

"We are delighted that Ram has been fully vindicated of these meritless allegations," former Mylan executive Ramkumar V. Rayapureddy's lead counsel, Adam Lurie, a partner at Linklaters, said of the outcome. "He has shown remarkable courage and resilience throughout this long injustice and is looking forward to moving on with his life and his career."
3 minute read

National Law Journal

'Irreparable Harm'?: US Judge Denies Big Pharma Motion to Halt FDA-Approved Generic Drug

"Novartis has not established on the current record that it is likely to suffer irreparable harm if injunctive relief is not granted," U.S. District Judge Dabney L. Friedrich wrote in her memorandum opinion denying Novartis's motion for a preliminary injunction without prejudice.
3 minute read

National Law Journal

'Monopoly Prices'?: Big Pharma Co. Amgen Accused of Anticompetitive Conduct

"A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998," according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.
3 minute read

New York Law Journal

What's Next for MDMA?

Amid clinicians, researchers and congressional lawmakers urging the FDA to approve MDMA for PTSD despite a negative vote by the FDA's advisory committee, the authors ask: What's next for MDMA?
12 minute read

Corporate Counsel

Fast-Growing Madrigal Pharma Names Veteran Health Care Lawyer Legal Chief

The Pennsylvania-based company promoted Shannon Kelley to her first general counsel post, just months after the successful launch of a drug to treat liver disease
3 minute read

Connecticut Law Tribune

Hundreds of Plaintiffs Deploy Litigation Strategy in Zantac Suits

"Juries can be fickle, and if you have to try nine cases nine times, you may get nine different results," Peter Bowman, a personal injury lawyer for BBB Attorneys, said.
3 minute read

New Jersey Law Journal

Gibbons on the Case: New Jersey Firm Launches 15 Suits for Drug Company

The suits stem from defendants' submission to the U.S. Food and Drug Administration of Abbreviated New Drug Applications [ANDA] seeking permission to manufacture generic versions of American Regent's selenious acid products before their patents expire.
2 minute read

New York Law Journal

Abbott Laboratories Wins Bid to Freeze Trusts of Defendants Accused of Evading Judgment

"The danger that the Goldmans will use SGE to continue dissipating their assets and attempting to evade the Court's judgment is glaringly obvious," the judge wrote in her decision.
3 minute read

Litigation Daily

Litigators of the Week: The Delaware Supreme Court Turns Its Spotlight on Advance Notice Bylaws

In the latest tug of war in Delaware law between activist investors and corporate boards, Teresa Goody Guillén and Richard Raile of Baker & Hostetler and John Seaman of Abrams & Bayliss represent Ted Kellner, an AIM ImmunoTech Inc. stockholder seeking board seats.
7 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now